Design, Synthesis, and Antiproliferative Activity of Benzopyran-4-One-Isoxazole Hybrid Compounds
Molecules · 2023
DOI: 10.3390/molecules28104220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Shilpi Gupta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinke…. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Antineoplastic Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Engineering Research Board (SERB) in partnership with Indo-US Science and Tech-nology Forum (IUSSTF), India, SERB Indo-US Postdoctoral Fellowship.
Abstract (Originalsprache)
The biological significance of benzopyran-4-ones as cytotoxic agents against multi-drug resistant cancer cell lines and isoxazoles as anti-inflammatory agents in cellular assays prompted us to design and synthesize their hybrid compounds and explore their antiproliferative activity against a panel of six cancer cell lines and two normal cell lines. Compounds 5a–d displayed significant antiproliferative activities against all the cancer cell lines tested, and IC50 values were in the range of 5.2–22.2 μM against MDA-MB-231 cancer cells, while they were minimally cytotoxic to the HEK-293 and LLC-PK1 normal cell lines. The IC50 values of 5a–d against normal HEK-293 cells were in the range of 102.4–293.2 μM. Compound 5a was screened for kinase inhibitory activity, proteolytic human serum stability, and apoptotic activity. The compound was found inactive towards different kinases, while it completely degraded after 2 h of incubation with human serum. At 5 μM concentration, it induced apoptosis in MDA-MB-231 by 50.8%. Overall, these findings suggest that new benzopyran-4-one-isoxazole hybrid compounds, particularly 5a–d, are selective anticancer agents, potentially safe for human cells, and could be synthesized at low cost. Additionally, Compound 5a exhibits potential anticancer activity mediated via inhibition of cancer cell proliferation and induction of apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, CA 92618-1908, USA.
- Department of Chemistry, Hindu College, Sonipat 131001, India.
- Biochemistry Division, Chemistry Department, Faculty of Science, Menoufia University, Shebin El-Koom 32512, Egypt.
ORCID-Profile: Shilpi Gupta, Shang Eun Park, Bishoy El-Aarag, Keykavous Parang, Rakesh Kumar Tiwari
Förderung
- Science and Engineering Research Board (SERB) in partnership with Indo-US Science and Tech-nology Forum (IUSSTF), India
- SERB Indo-US Postdoctoral Fellowship
Zitieren
APA
Gupta, S., Park, S. E., Mozaffari, S., El-Aarag, B., Parang, K., & Tiwari, R. K. (2023). Design, Synthesis, and Antiproliferative Activity of Benzopyran-4-One-Isoxazole Hybrid Compounds. Molecules. https://doi.org/10.3390/molecules28104220
Vancouver
Gupta S, Park SE, Mozaffari S, El-Aarag B, Parang K, Tiwari RK. Design, Synthesis, and Antiproliferative Activity of Benzopyran-4-One-Isoxazole Hybrid Compounds. Molecules. 2023. doi:10.3390/molecules28104220
BibTeX
@article{Gupta2023,
author = {Gupta, Shilpi and Park, Shang Eun and Mozaffari, Saghar and El-Aarag, Bishoy and Parang, Keykavous and Tiwari, Rakesh Kumar},
title = {Design, Synthesis, and Antiproliferative Activity of Benzopyran-4-One-Isoxazole Hybrid Compounds},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28104220}
}
EUVIMED